# Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China

> **NCT03633838** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5067 (actual)

## Conditions studied

- Acute Exacerbation of Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03633838
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-28
- **Primary completion:** 2017-02-28
- **Final completion:** 2017-02-28
- **Target enrollment:** 5067 (ACTUAL)
- **Last updated:** 2018-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03633838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03633838, "Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03633838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*